Navigation Links
Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
Date:11/13/2013

Columbus, OH (PRWEB) November 13, 2013

As The Courts Continue To Receive Pradaxa Lawsuits, Wright & Schulte LLC Files A Pradaxa Internal Bleeding Lawsuit Aleging A Woman’s Wrongful Death Was From a Gastrointestinal Hemorrhage Due To Pradaxa

Pradaxa internal bleeding lawsuits alleging serious injury and wrongful death due to Pradaxa bleeding side effects continue to mount in courts around the country, Wright & Schulte LLC reports. According to court documents filed in U.S. District Court, Eastern District of Pennsylvania, the most recent Pradaxa internal bleeding wrongful death claim was filed by two daughters who allege that a fatal gastrointestinal hemorrhage suffered by their mother was the result of Pradaxa. (Case No. 2:13-cv-06488-GP)

According to the Pradaxa lawsuit, the Plaintiffs’ mother began taking the blood thinner in early 2012 to treat non-valvular atrial fibrillation, a disorder associated with an increased risk of stroke. Four months after the drug was first prescribed, the woman to suffer a gastrointestinal hemorrhage and subsequently died after being taken to the Hospital of the University of Pennsylvania. The complaint asserts that the “excessive and/or uncontrollable bleeding” suffered by the woman and which resulted in her death “was caused and/or worsened by Plaintiff’s use of Pradaxa.”

The complaint further alleges that Boehringer Ingelheim Pharmaceuticals, the manufacturer of the drug, over-promoted Pradaxa, and knew or should have known that Pradaxa’s original labeling did not adequately disclose its risks, including the fact that there is no reversal agent currently available to stop Pradaxa bleeding. Finally, the Pradaxa lawsuit alleges that due to her use of Pradaxa, the decedent suffered physical pain, mental anguish, the need for lifelong medical treatment and eventual death. It seeks both compensatory and punitive damages for counts of strict products liability, negligence, negligent misrepresentation and/or fraud, breach of implied and express warranties, negligence per se, and fraudulent concealment.

Bloomberg News reported late last year that Pradaxa’s risk of life-threatening internal bleeding has prompted regulators in several countries to issue safety alerts for the drug. According to the Pradaxa lawsuit filed in Pennsylvania, Pradaxa was touted by its manufacturer as being safer than warfarin, an anti-coagulant which has been in use for decades. But while both blood thinners can cause episodes of serious internal bleeding, the Bloomberg report pointed out that hemorrhaging from warfarin can be easily stopped with the administration of vitamin K.
[bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html; Bloomberg, December 11, 2012]

According to Wright & Schulte LLC, the recently filed Pradaxa internal bleeding lawsuit echoes allegations made in hundreds of similar Pradaxa bleeding lawsuits now pending in a federal multidistrict litigation underway in U.S. District Court, Southern District of Illinois. The litigation’s first trial of a Pradaxa lawsuit is scheduled to begin on August 11, 2014, foll¬¬owed by trials on November 3, 2014, January 5, 2015 and February 6, 2015.
[ilsd.uscourts.gov/mdl/mdl2385.aspx]

For more information on Pradaxa lawsuit like us on Facebook.

Wright & Schulte LLC is already representing plaintiffs in Pradaxa lawsuits that have been filed in the federal multidistrict litigation, and continues to offer free legal consultations to alleged victims of Pradaxa bleeding side effects. For more information on filing a Pradaxa bleeding lawsuit, or to arrange for a free legal consultation, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Pradaxa lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11328615.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation
2. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
3. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
4. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
5. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
6. Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar
7. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
9. Pradaxa Bleeding Lawsuits Help: Resource4thePeople Reports another Medical Research Study Finds Increased Bleeding Risks
10. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
11. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: